Oscar Health (NYSE:OSCR) Receives New Coverage from Analysts at Piper Sandler

Piper Sandler started coverage on shares of Oscar Health (NYSE:OSCR) in a research report sent to investors on Wednesday, MarketBeat.com reports. The brokerage issued an overweight rating and a $25.00 price objective on the stock.

Several other brokerages have also recently weighed in on OSCR. The Goldman Sachs Group lifted their price objective on shares of Oscar Health from $16.00 to $21.00 and gave the stock a neutral rating in a research note on Thursday, May 9th. Wells Fargo & Company lifted their price objective on shares of Oscar Health from $24.00 to $27.00 and gave the stock an overweight rating in a research note on Wednesday, June 12th. Bank of America reiterated a neutral rating and issued a $21.00 price objective (down previously from $25.00) on shares of Oscar Health in a research note on Thursday, May 30th. Raymond James began coverage on shares of Oscar Health in a research note on Friday, March 22nd. They issued an outperform rating and a $20.00 price objective for the company. Finally, Robert W. Baird began coverage on shares of Oscar Health in a research note on Thursday, May 30th. They issued an outperform rating and a $28.00 price objective for the company. Three analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has an average rating of Moderate Buy and a consensus price target of $19.75.

Oscar Health Stock Performance

Shares of OSCR stock opened at $15.79 on Wednesday. The company has a market capitalization of $3.75 billion, a price-to-earnings ratio of -39.48 and a beta of 1.68. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.10 and a current ratio of 1.10. The company has a 50-day simple moving average of $19.49 and a 200 day simple moving average of $15.32. Oscar Health has a 52 week low of $4.72 and a 52 week high of $23.44.

Oscar Health (NYSE:OSCR) last announced its earnings results on Tuesday, May 7th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.28 by $0.34. Oscar Health had a negative net margin of 0.82% and a negative return on equity of 5.77%. The business had revenue of $2.14 billion during the quarter, compared to the consensus estimate of $1.99 billion. During the same quarter in the previous year, the firm posted ($0.18) EPS. Oscar Health’s revenue was up 45.8% compared to the same quarter last year. On average, sell-side analysts predict that Oscar Health will post -0.05 earnings per share for the current year.

Insider Activity at Oscar Health

In related news, EVP Alessandrea C. Quane sold 25,550 shares of Oscar Health stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total transaction of $497,203.00. Following the sale, the executive vice president now directly owns 237,347 shares of the company’s stock, valued at approximately $4,618,772.62. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Alessandrea C. Quane sold 25,550 shares of Oscar Health stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total transaction of $497,203.00. Following the sale, the executive vice president now directly owns 237,347 shares of the company’s stock, valued at approximately $4,618,772.62. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Mario Schlosser sold 5,808 shares of Oscar Health stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total transaction of $113,023.68. Following the sale, the insider now directly owns 65,920 shares in the company, valued at $1,282,803.20. The disclosure for this sale can be found here. In the last three months, insiders have sold 81,655 shares of company stock valued at $1,589,006. 25.11% of the stock is owned by insiders.

Institutional Investors Weigh In On Oscar Health

A number of institutional investors have recently added to or reduced their stakes in OSCR. Avalon Trust Co bought a new stake in Oscar Health during the 1st quarter worth approximately $69,000. Prevail Innovative Wealth Advisors LLC bought a new stake in shares of Oscar Health in the 4th quarter valued at $92,000. Handelsbanken Fonder AB bought a new stake in shares of Oscar Health in the 4th quarter valued at $110,000. QRG Capital Management Inc. bought a new stake in shares of Oscar Health in the 3rd quarter valued at $117,000. Finally, Focus Financial Network Inc. ADV bought a new stake in shares of Oscar Health in the 4th quarter valued at $152,000. 75.70% of the stock is owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.